ClinicalTrials.Veeva

Menu

Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Cocaine-related Disorders

Treatments

Behavioral: Cognitive behavioral therapy (CBT)

Study type

Interventional

Funder types

Other

Identifiers

NCT00877435
SNF-105314-120675

Details and patient eligibility

About

The purpose of this study is to determine whether prize-based contingency management (prizeCM) combined with cognitive behavioral therapy (CBT) is more effective in the treatment of of cocaine-dependent patients compared to CBT only. Patients were randomized to prizeCM + CBT (experimental group) or to CBT (control group) an treated over 24 weeks. It is the first trial of this type in Europe.

Enrollment

60 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cocaine dependence, aged 18 or older, other dependences

Exclusion criteria

  • severe somatic, brain, or psychiatric disease, attention deficit disorders with medication methylphenidate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

1
Experimental group
Description:
Cognitive behavioral therapy (CBT) + prize-based contingency management (prizeCM)
Treatment:
Behavioral: Cognitive behavioral therapy (CBT)
2
Active Comparator group
Description:
Cognitive behavioral therapy (CBT)
Treatment:
Behavioral: Cognitive behavioral therapy (CBT)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems